BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 18237000)

  • 1. Low-dose intravenous gammaglobulin in the treatment of severe autoimmune urticaria.
    Pereira C; Tavares B; Carrapatoso I; Loureiro G; Faria E; Machado D; Chieira C
    Eur Ann Allergy Clin Immunol; 2007 Sep; 39(7):237-42. PubMed ID: 18237000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high-dose intravenous immunoglobulin treatment in therapy-resistant chronic spontaneous urticaria.
    Mitzel-Kaoukhov H; Staubach P; Müller-Brenne T
    Ann Allergy Asthma Immunol; 2010 Mar; 104(3):253-8. PubMed ID: 20377115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamide.
    Bernstein JA; Garramone SM; Lower EG
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):212-4. PubMed ID: 12197581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation.
    Reeves GE; Boyle MJ; Bonfield J; Dobson P; Loewenthal M
    Intern Med J; 2004 Apr; 34(4):182-6. PubMed ID: 15086698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate: a useful steroid-sparing agent in recalcitrant chronic urticaria.
    Perez A; Woods A; Grattan CE
    Br J Dermatol; 2010 Jan; 162(1):191-4. PubMed ID: 19903174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris.
    Engineer L; Bhol KC; Ahmed AR
    J Am Acad Dermatol; 2000 Dec; 43(6):1049-57. PubMed ID: 11100022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid autoimmunity in chronic urticaria.
    O'Donnell BF; Francis DM; Swana GT; Seed PT; Kobza Black A; Greaves MW
    Br J Dermatol; 2005 Aug; 153(2):331-5. PubMed ID: 16086744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of corticosteroid withdrawal in chronic urticaria: a prospective study of 17 patients].
    Augey F; Guillot-Pouget I; Gunera-Saad N; Berard F; Nicolas JF
    Ann Dermatol Venereol; 2008 Jan; 135(1):21-5. PubMed ID: 18342069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of thromboembolic risk related to high-dose intravenous immunoglobulin treatment: a preliminary clinical study of 10 patients with autoimmune mucocutaneous blistering diseases.
    Mignogna MD; Fortuna G; Leuci S; Ruoppo E; Adamo D; Fedele S
    Clin Exp Dermatol; 2009 Mar; 34(2):145-50. PubMed ID: 19187294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic autoimmune urticaria: treatment with omalizumab].
    Máspero JF; Parisi CA; De Gennaro M; Benhabib O; Lampert M
    Arch Argent Pediatr; 2009 Oct; 107(5):452-6. PubMed ID: 19809768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up.
    Sami N; Letko E; Androudi S; Daoud Y; Foster CS; Ahmed AR
    Ophthalmology; 2004 Jul; 111(7):1380-2. PubMed ID: 15234140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema.
    Engler RJ; Squire E; Benson P
    Ann Allergy Asthma Immunol; 1995 Feb; 74(2):155-9. PubMed ID: 7697475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin in autoimmune chronic urticaria.
    O'Donnell BF; Barr RM; Black AK; Francis DM; Kermani F; Niimi N; Barlow RJ; Winkelmann RK; Greaves MW
    Br J Dermatol; 1998 Jan; 138(1):101-6. PubMed ID: 9536230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of basophil histamine release against the autologous serum skin test and outcome of serum-induced basophil histamine release studies in a large population of chronic urticaria patients.
    Platzer MH; Grattan CE; Poulsen LK; Skov PS
    Allergy; 2005 Sep; 60(9):1152-6. PubMed ID: 16076300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
    Fazekas F; Lublin FD; Li D; Freedman MS; Hartung HP; Rieckmann P; Sørensen PS; Maas-Enriquez M; Sommerauer B; Hanna K; ;
    Neurology; 2008 Jul; 71(4):265-71. PubMed ID: 18645164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous occurrence of chronic autoimmune urticaria and non-allergic asthma: a common mechanism?
    Tedeschi A; Cottini M; Asero R
    Eur Ann Allergy Clin Immunol; 2009 Apr; 41(2):56-9. PubMed ID: 19585861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic autoimmune urticaria in children.
    Dodig S; Richter D
    Acta Dermatovenerol Croat; 2008; 16(2):65-71. PubMed ID: 18541101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urticaria and urticaria related skin condition/disease in children.
    Novembre E; Cianferoni A; Mori F; Barni S; Calogero C; Bernardini R; Di Grande L; Pucci N; Azzari C; Vierucci A
    Eur Ann Allergy Clin Immunol; 2008 May; 40(1):5-13. PubMed ID: 18700329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of autoimmune urticaria with low-dose cyclosporin A: A one-year follow-up.
    Boubouka CD; Charissi C; Kouimintzis D; Kalogeromitros D; Stavropoulos PG; Katsarou A
    Acta Derm Venereol; 2011 Jan; 91(1):50-4. PubMed ID: 21264453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.